Abstract
Gangliogliomas are glioneuronal neoplasms, generally with a benign evolution, accounting for the most common tumours in patients with long-term pharmacoresistant epilepsy. BRAF(V) (600E) has been detected in a high percentage of World Health Organization grade 1 gangliogliomas. However, biopsy collections from epilepsy patients include tumours that meet neuropathological ganglioglioma criteria but lack the BRAF(V) (600E) mutation. The molecular pathology of such BRAF(V600E)-negative gangliogliomas remains largely unexplored. We here focused on decoding the molecular and cellular profiles of these BRAF(V600E)-negative gangliogliomas at the single-cell resolution. Our results identify an exclusive profile in excitatory, but not inhibitory, neurons, astrocytes and oligodendrocytes in BRAF(V600E)-negative gangliogliomas. Moreover, we confirm the presence of immature excitatory neurons with higher expression of genes related to glutamatergic transmission as well as metabolically active astro- and oligodendrocytes which may contribute to epileptogenicity. Our study provides important resources to understand the molecular profile of BRAF(V600E)-negative gangliogliomas aiming to drive forward future research directions to novel and tailored treatment options for epilepsy.